Effect of ramipril/hydrochlorothiazide and ramipril/canrenone combination on atrial fibrillation recurrence in hypertensive type 2 diabetic patients with and without cardiac autonomic neuropathy.
CONCLUSIONS: These findings suggest that in type 2 diabetic hypertensives, ramipril/canrenone treatment was more effective than ramipril/HCTZ in reducing AF recurrence. This could be related to the greater improvement in cardiac fibrosis.
PMID: 28507568 [PubMed]
Source: Archives of Medical Science - Category: Biomedical Science Tags: Arch Med Sci Source Type: research
More News: Atrial Fibrillation | Biomedical Science | Brain | Diabetes | Diabetes Type 2 | Endocrinology | Hydrochlorothiazide | Neurology | Neuroscience | Norvasc | Science | Study